These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26508185)

  • 21. [Current state of diagnosis and treatment of incomplete Kawasaki disease].
    Zhang QY; Du JB
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):339-41. PubMed ID: 16780709
    [No Abstract]   [Full Text] [Related]  

  • 22. [Elective phagocytosis of polynuclear neutrophils caused by medullary macrophages and autoimmune neutropenia in children].
    Gbadoe AD; Fenneteau O; Duval M; Rohrlich P; Cartron J; Vilmer E
    Arch Pediatr; 1997 May; 4(5):398-405. PubMed ID: 9230986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
    Fujimaru T; Ito S; Masuda H; Oana S; Kamei K; Ishiguro A; Kato H; Abe J
    Cytokine; 2014 Dec; 70(2):156-60. PubMed ID: 25082649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensorineural hearing loss: an underdiagnosed complication of Kawasaki disease.
    Magalhães CM; Magalhães Alves NR; Oliveira KM; Silva IM; Gandolfi L; Pratesi R
    J Clin Rheumatol; 2010 Oct; 16(7):322-5. PubMed ID: 20859226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemolytic uraemic syndrome with peripheral gangrene and Kawasaki disease in a 15-month-old child.
    Krishnamurthy S; Jagadeesh A; Chandrasekaran V; Mahadevan S; Rajesh NG
    Paediatr Int Child Health; 2017 Feb; 37(1):70-73. PubMed ID: 26752398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum granulocyte colony-stimulating factor correlates with coronary artery dilatation in Kawasaki disease.
    Samada K; Igarashi H; Shiraishi H; Hatake K; Momoi MY
    Eur J Pediatr; 2002 Oct; 161(10):538-41. PubMed ID: 12297900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kawasaki disease and hepatobiliary involvement: report of two cases.
    Keeling IM; Beran E; Dapunt OE
    Ital J Pediatr; 2016 Mar; 42():27. PubMed ID: 26951087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kawasaki disease in central area of Northeast Thailand.
    Panamonta M; Chaikitpinyo A; Durongpisitkul K; Somchit S; Petcharatana S; Wongswadiwat Y; Kosalaraksa P; Lumbiganon P
    J Med Assoc Thai; 2004 Aug; 87(8):887-90. PubMed ID: 15471291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H; Takeshita S; Nakatani K; Kawamura Y; Tokutomi T; Sekine I
    Clin Immunol; 2002 May; 103(2):161-8. PubMed ID: 12027421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC; Vincenti M; Darras JP; Lalande M; Rodière M; Filleron A
    Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of neutrophil activation cytokines in Kawasaki disease.
    Suzuki H; Noda E; Miyawaki M; Takeuchi T; Uemura S; Koike M
    Pediatr Int; 2001 Apr; 43(2):115-9. PubMed ID: 11285059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic neutropenia associated with autoimmune disease.
    Starkebaum G
    Semin Hematol; 2002 Apr; 39(2):121-7. PubMed ID: 11957195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy.
    Corbacioglu S; Bux J; König A; Gabrilove JL; Welte K; Bussel JB
    J Pediatr; 2000 Jul; 137(1):96-9. PubMed ID: 10891829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune neutropenia.
    Autrel-Moignet A; Lamy T
    Presse Med; 2014 Apr; 43(4 Pt 2):e105-18. PubMed ID: 24680423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kawasaki disease shock syndrome: a severe form of Kawasaki disease.
    İşgüder R; Doksöz Ö; Bağ Ö; Ağın H; Meşe T; Karaarslan ÜU; Devrim İ
    Turk J Pediatr; 2013; 55(3):319-21. PubMed ID: 24217080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kawasaki disease in adult patients].
    Sève P; Lega JC
    Rev Med Interne; 2011 Jan; 32(1):17-25. PubMed ID: 20537446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.